Heart Pump Device Market Size, Share and Growth Outlook, 2026

Heart Pump Device Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Heart Pump Device Market size is forecast to increase from $5.42 Billion in 2026 to $14.51 Billion in 2034 at a CAGR of 13.1% between 2026 and 2034.

The Heart Pump Device market report provides detailed analysis and outlook of Heart Pump Device segments including By Product (Ventricular Assist Devices, Intra-aortic Balloon Pumps, Total Artificial Heart ), By Type (Implantable Heart Pump Devices, Extracorporeal Heart Pump Devices), By Therapy (Bridge-to-transplant, Bridge-to-candidacy, Destination Therapy, Bridge-to-recovery), By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Heart Pump Device Industry Overview

Advanced Mechanical Circulatory Support Technologies Are Reshaping Cardiac Care

The heart pump device industry continues to evolve through innovations focused on heart failure management, mechanical circulatory support, and transplant optimization. Heart pump technologies play a critical role in supporting patients with advanced cardiovascular disease, offering life-sustaining assistance during acute cardiac events, chronic heart failure progression, and organ transplantation procedures. Manufacturers are increasingly investing in remote monitoring systems, next-generation ventricular assist devices, and donor organ preservation technologies to improve patient outcomes and expand treatment possibilities. The convergence of digital health, implantable sensors, and advanced perfusion systems is transforming how clinicians monitor and manage severe cardiac conditions.

Remote Monitoring Solutions Support Earlier Heart Failure Intervention

A significant trend within the heart pump device industry is the integration of remote monitoring technologies designed to identify worsening heart failure before advanced mechanical support becomes necessary. Abbott Laboratories received U.S. Food and Drug Administration approval for its next-generation CardioMEMS HF System reader, which works in conjunction with an implanted pulmonary artery sensor. The device continuously measures pressure changes associated with heart failure progression and transmits data directly from patients' homes to clinical care teams. By functioning as an early warning system, the platform enables physicians to adjust therapies proactively, potentially reducing hospitalizations and delaying the need for left ventricular assist devices or other advanced heart pump interventions. This development highlights the industry's growing focus on preventive cardiovascular management and connected care solutions.

Device Safety and Reliability Remain Critical Industry Priorities

As heart pump technologies become increasingly sophisticated, regulatory oversight and post-market surveillance continue to play an essential role in ensuring patient safety. The U.S. Food and Drug Administration issued an urgent safety communication regarding a voluntary recall involving specific Impella CP Heart Pumps with SmartAssist manufactured by Johnson & Johnson MedTech. The communication identified a design specification deviation that may result in low purge pressure events, persistent alarms, or sudden loss of mechanical circulatory support. This event underscores the importance of rigorous quality assurance programs, continuous device monitoring, and proactive risk management within the heart pump device industry. Manufacturers remain focused on enhancing device reliability and maintaining high standards of patient safety across mechanical support platforms.

Organ Preservation Technologies Expand Transplant Opportunities

The heart pump device industry is also advancing beyond patient support applications into donor organ preservation and transplantation. TransMedics Group received full and unconditional Investigational Device Exemption approval from the U.S. Food and Drug Administration for its OCS Heart ENHANCE clinical study. The company's Organ Care System utilizes portable warm perfusion technology to preserve, assess, and optimize donor hearts outside the body before transplantation. Unlike traditional cold storage methods, the system maintains organs in a functioning state, potentially improving transplant outcomes and expanding the availability of suitable donor hearts. These advancements are helping reshape transplant medicine by improving organ viability and supporting more effective donor heart utilization.

Heart Pump Device Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Heart Pump Device market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Abbott Laboratories, Medtronic plc, Getinge AB, Terumo Corporation, LivaNova PLC, SynCardia Systems, LLC, CARMAT SA, Jarvik Heart, Inc., BiVACOR Inc., CorWave SA. The Heart Pump Device market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Heart Pump Device industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Heart Pump Device Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Heart Pump Device companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Heart Pump Device markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Heart Pump Device Market Competitive Benchmarking and Company Analysis

Leading companies in Heart Pump Device industry include- Abbott Laboratories, Medtronic plc, Getinge AB, Terumo Corporation, LivaNova PLC, SynCardia Systems, LLC, CARMAT SA, Jarvik Heart, Inc., BiVACOR Inc., CorWave SA. The Heart Pump Device market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Heart Pump Device Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Heart Pump Device market remains one of the strongest-performing segments in the country.
The US Heart Pump Device Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Heart Pump Device market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Heart Pump Device industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Heart Pump Device markets

Canada's strong Heart Pump Device sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Heart Pump Device market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Heart Pump Device Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Heart Pump Device market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Heart Pump Device population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Heart Pump Device industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Heart Pump Device market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Heart Pump Device sales through 2034

France Heart Pump Device companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Heart Pump Device Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Heart Pump Device distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Heart Pump Device Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Heart Pump Device market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Heart Pump Device industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Heart Pump Device industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Heart Pump Device Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Heart Pump Device market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Heart Pump Device market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Heart Pump Device Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Heart Pump Device Market Segmentation

By Product
Ventricular Assist Devices
Intra-aortic Balloon Pumps
Total Artificial Heart
By Type
Implantable Heart Pump Devices
Extracorporeal Heart Pump Devices
By Therapy
Bridge-to-transplant
Bridge-to-candidacy
Destination Therapy
Bridge-to-recovery
By End User
Hospitals
Ambulatory Surgical Centers
Cardiac Centers

Top Companies in Heart Pump Device Industry

Abbott Laboratories
Medtronic plc
Getinge AB
Terumo Corporation
LivaNova PLC
SynCardia Systems, LLC
CARMAT SA
Jarvik Heart, Inc.
BiVACOR Inc.
CorWave SA

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025